tiprankstipranks
Trending News
More News >
Praxis Precision Medicines, Inc. (PRAX)
:PRAX
US Market
Advertisement

Praxis Precision Medicines (PRAX) Ratios

Compare
648 Followers

Praxis Precision Medicines Ratios

PRAX's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, PRAX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
8.44 5.39 3.12 7.64 19.23
Quick Ratio
8.44 5.39 3.12 7.64 19.23
Cash Ratio
4.19 5.16 1.73 3.69 18.87
Solvency Ratio
-5.37 -6.72 -5.43 -3.94 -3.89
Operating Cash Flow Ratio
-4.15 -7.06 -5.21 -3.31 -3.35
Short-Term Operating Cash Flow Coverage
-153.76 0.00 0.00 0.00 -68.97
Net Current Asset Value
$ 294.05M$ 66.60M$ 71.82M$ 245.47M$ 286.61M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.03 0.04 0.01 <0.01
Debt-to-Equity Ratio
<0.01 0.04 0.06 0.02 <0.01
Debt-to-Capital Ratio
<0.01 0.03 0.06 0.02 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.09 1.26 1.51 1.17 1.05
Debt Service Coverage Ratio
-218.21 0.00 0.00 0.00 -80.04
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
<0.01 0.00 0.00 0.00 <0.01
Interest Debt Per Share
0.05 0.38 1.47 1.52 1.28
Net Debt to EBITDA
0.71 0.63 0.27 0.81 4.84
Profitability Margins
Gross Profit Margin
98.10%100.00%0.00%0.00%0.00%
EBIT Margin
-2868.84%-5164.41%0.00%0.00%0.00%
EBITDA Margin
-2865.23%-5146.75%0.00%0.00%0.00%
Operating Profit Margin
-2868.84%-5164.41%0.00%0.00%0.00%
Pretax Profit Margin
-2617.11%-5037.88%0.00%0.00%0.00%
Net Profit Margin
-2617.11%-5037.88%0.00%0.00%0.00%
Continuous Operations Profit Margin
-2617.11%-5037.88%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%99.55%99.89%99.99%
EBT Per EBIT
91.23%97.55%99.55%99.84%99.77%
Return on Assets (ROA)
-44.40%-140.17%-185.07%-57.00%-20.39%
Return on Equity (ROE)
-50.42%-176.95%-279.97%-66.54%-21.51%
Return on Capital Employed (ROCE)
-53.05%-175.03%-270.06%-65.59%-21.56%
Return on Invested Capital (ROIC)
-52.90%-172.35%-265.50%-65.31%-21.44%
Return on Tangible Assets
-44.40%-140.17%-185.07%-57.00%-20.39%
Earnings Yield
-19.45%-83.91%-194.21%-19.95%-12.55%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
<0.01 0.00 0.08 0.15 0.18
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
7.19 0.92 0.00 0.00 0.00
Asset Turnover
0.02 0.03 0.00 0.00 0.00
Working Capital Turnover Ratio
0.02 0.03 0.00 0.00 0.00
Cash Conversion Cycle
-54.30K 0.00 -4.57K -2.47K -2.00K
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
54.30K 0.00 4.57K 2.47K 2.00K
Operating Cycle
0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
-7.78 -16.85 -60.21 -44.01 -88.19
Free Cash Flow Per Share
-7.78 -16.86 -60.36 -44.38 -88.19
CapEx Per Share
<0.01 <0.01 0.14 0.37 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
-2.56K -2.22K -416.76 -118.62 -13.16K
Capital Expenditure Coverage Ratio
-2.56K -2.22K -416.76 -118.62 -13.16K
Operating Cash Flow Coverage Ratio
-153.76 -44.54 -41.08 -28.89 -68.97
Operating Cash Flow to Sales Ratio
-20.18 -45.42 0.00 0.00 0.00
Free Cash Flow Yield
-15.50%-75.68%-169.07%-15.02%-10.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-5.15 -1.19 -0.51 -5.01 -7.97
Price-to-Sales (P/S) Ratio
130.51 60.04 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
2.49 2.11 1.44 3.33 1.71
Price-to-Free Cash Flow (P/FCF) Ratio
-6.47 -1.32 -0.59 -6.66 -9.36
Price-to-Operating Cash Flow Ratio
-6.69 -1.32 -0.59 -6.71 -9.36
Price-to-Earnings Growth (PEG) Ratio
1.18 0.02 -0.03 0.12 0.11
Price-to-Fair Value
2.49 2.11 1.44 3.33 1.71
Enterprise Value Multiple
-3.85 -0.54 -0.25 -4.24 -3.22
Enterprise Value
892.45M 68.12M 52.60M 701.95M 196.59M
EV to EBITDA
-3.83 -0.54 -0.25 -4.24 -3.22
EV to Sales
109.88 27.84 0.00 0.00 0.00
EV to Free Cash Flow
-5.45 -0.61 -0.28 -5.59 -3.74
EV to Operating Cash Flow
-5.44 -0.61 -0.28 -5.64 -3.74
Tangible Book Value Per Share
20.86 10.57 24.77 88.62 481.76
Shareholders’ Equity Per Share
20.86 10.57 24.77 88.62 481.76
Tax and Other Ratios
Effective Tax Rate
<0.01 0.00 <0.01 <0.01 <0.01
Revenue Per Share
0.39 0.37 0.00 0.00 0.00
Net Income Per Share
-10.10 -18.69 -69.33 -58.96 -103.61
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
0.91 0.98 1.00 1.00 1.00
Research & Development to Revenue
22.93 35.46 0.00 0.00 0.00
SG&A to Revenue
6.76 17.19 0.00 0.00 0.00
Stock-Based Compensation to Revenue
4.39 10.16 0.00 0.00 0.00
Income Quality
0.77 0.90 0.86 0.75 0.85
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis